Trial Profile
Vandetanib under fed or fasting conditions in male or female volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Jan 2012
Price :
$35
*
At a glance
- Drugs Vandetanib (Primary)
- Indications Biliary cancer; Breast cancer; Prostate cancer; Thyroid cancer
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 12 Jan 2012 New trial record
- 27 Dec 2011 Results published in Clinical Therapeutics.